IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:1975-1982.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.03-0898

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Michaelides, M.
Right arrow Articles by Hunt, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michaelides, M.
Right arrow Articles by Hunt, D. M.

Progressive Cone Dystrophy Associated with Mutation in CNGB3

Michel Michaelides,1,2 Irene A. Aligianis,2,3,4 John R. Ainsworth,5 Peter Good,5 John D. Mollon,6 Eamonn R. Maher,3,4 Anthony T. Moore,1 and David M. Hunt1

1From the Institute of Ophthalmology, University College London, London, United Kingdom; the 3Section of Medical and Molecular Genetics, Department of Paediatrics and Child Health, University of Birmingham, Birmingham, United Kingdom; the 4West Midlands Regional Genetics Service, Birmingham Women’s Hospital, Birmingham, United Kingdom; the 5Department of Ophthalmology, Birmingham Children’s Hospital, Birmingham, United Kingdom; and the 6Department of Experimental Psychology, University of Cambridge, Cambridge, United Kingdom.

PURPOSE. To determine the molecular basis for phenotypic variability in a three-generation consanguineous family containing a single individual with complete achromatopsia and three individuals with progressive cone dystrophy.

METHODS. Four affected individuals underwent ophthalmic examination, electrophysiological assessment, color fundus photography, and psychophysical testing. Blood samples were obtained for DNA extraction and mutation screening of the cone-specific cGMP-gated (CNG) channel protein gene CNGB3 was undertaken.

RESULTS. The clinical findings in one family member were consistent with a diagnosis of complete achromatopsia, with nystagmus, photophobia, and poor visual acuity from early infancy and complete color-blindness, normal fundi, and absent cone responses with normal rod responses on electroretinography (ERG). Mutation analysis revealed her to be homozygous for the common CNGB3 achromatopsia mutation, 1148delC (Thr383fs). In contrast, the three other symptomatic individuals in the family had findings consistent with progressive cone dystrophy. Their visual problems began later in childhood (ranging from 3 to 14 years of age) and there was evidence of progressive deterioration in cone function. All three had a marked tritanopic color vision defect and fundoscopy revealed bilateral macular atrophy. Electrophysiological testing of these three subjects demonstrated clear evidence of progressive deterioration of cone responses over time; rod responses were normal. All three individuals with this progressive phenotype were found to be compound heterozygotes for the 1148delC (Thr383fs) frameshift mutation and a novel Arg403Gln missense mutation in CNGB3.

CONCLUSIONS. Mutations in CNGB3, which have been shown to cause achromatopsia, are now shown to be associated with autosomal recessive progressive cone dystrophy. In this study, a novel Arg403Gln mutation was identified, located in the middle of the pore domain of the cone CNG cation channel ß-subunit, which when associated with the nonsense mutation Thr383fs, resulted in progressive cone dystrophy.





This article has been cited by other articles:


Home page
IOVSHome page
N. W. Khan, B. Wissinger, S. Kohl, and P. A. Sieving
CNGB3 Achromatopsia with Progressive Loss of Residual Cone Function and Impaired Rod-Mediated Function
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3864 - 3871.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. Chang, M. S. Dacey, N. L. Hawes, P. F. Hitchcock, A. H. Milam, P. Atmaca-Sonmez, S. Nusinowitz, and J. R. Heckenlively
Cone Photoreceptor Function Loss-3, a Novel Mouse Model of Achromatopsia Due to a Mutation in Gnat2
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5017 - 5021.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology